Abstract
680P Comparative efficacy of first-line novel anti-androgen therapies versus docetaxel in metastatic hormone sensitive prostate cancer (mHSPC): An updated network meta-analysis
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have